Sign In
test

Robert Hopfner

Pivotal Bioventure Partners Investment Advisor Llc

Assets Managed
$279.778M
Holdings
13
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
8.17%(2Q avg: 28.85%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Pivotal Bioventure Partners Investment Advisor Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 13 positions.

Assets under management

The assets under management (AUM) of Pivotal Bioventure Partners Investment Advisor Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 279.778M in assets, with a quarterly growth rate of 8.17% and a 2-quarter average growth rate of 28.85%. The portfolio is managed by Robert Hopfner, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PCVX
Vaxcyte Inc
Recent Activity
28.51%
$79.752M
1.372M shares@ $58.12 avg price
OCS
Oculis Holding Ag
Recent Activity
Decreased -26.58%
15.97%
$44.679M
1.68M shares@ $26.6 avg price
EVMN
Evommune Inc
Recent Activity
15.84%
$44.3M
1.927M shares@ $23.0 avg price
ARQT
Arcutis Biotherapeutics Inc
Recent Activity
Decreased -0.78%
11.42%
$31.945M
1.356M shares@ $23.57 avg price
TRVI
Trevi Therapeutics Inc
Recent Activity
Increased 23.63%
6.63%
$18.536M
1.554M shares@ $11.93 avg price
IMNM
Immunome Inc
Recent Activity
5.73%
$16.02M
732,512 shares@ $21.87 avg price
MPLT
Maplight Therapeutics Inc
Recent Activity
4.45%
$12.431M
611,447 shares@ $20.34 avg price
ZBIO
Zenas Biopharma Inc
Recent Activity
4.14%
$11.573M
591,991 shares@ $19.55 avg price
BIOA
Bioage Labs Inc
Recent Activity
4.09%
$11.428M
653,374 shares@ $17.49 avg price
AVTX
Avalo Therapeutics Inc
Recent Activity
New Position
1.58%
$4.418M
295,933 shares@ $14.94 avg price

1-10 of 13